Literature DB >> 11313270

Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome.

B Corneo1, D Moshous, T Güngör, N Wulffraat, P Philippet, F L Le Deist, A Fischer, J P de Villartay.   

Abstract

Omenn syndrome (OS) is an inherited disorder characterized by an absence of circulating B cells and an infiltration of the skin and the intestine by activated oligoclonal T lymphocytes, indicating that a profound defect in the lymphoid developmental program could be accountable for this condition. Inherited mutations in either the recombination activating genes RAG1 or RAG2, resulting in partial V(D)J recombinase activity, were shown to be responsible for OS. This study reports on the characterization of new RAG1/2 gene mutations in a series of 9 patients with OS. Given the occurrence of the same mutations in patients with T-B-severe combined immune deficiency or OS on 3 separate occasions, the proposal is made that an additional factor may be required in certain circumstances for the development of the Omenn phenotype. The nature of this factor is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313270     DOI: 10.1182/blood.v97.9.2772

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  60 in total

1.  Mutational analysis of all conserved basic amino acids in RAG-1 reveals catalytic, step arrest, and joining-deficient mutants in the V(D)J recombinase.

Authors:  Leslie E Huye; Mary M Purugganan; Ming-Ming Jiang; David B Roth
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 2.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

3.  Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications.

Authors:  Veronica Marrella; Pietro L Poliani; Elena Fontana; Anna Casati; Virginia Maina; Barbara Cassani; Francesca Ficara; Manuela Cominelli; Francesca Schena; Marianna Paulis; Elisabetta Traggiai; Paolo Vezzoni; Fabio Grassi; Anna Villa
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

Review 4.  RAG gene defects at the verge of immunodeficiency and immune dysregulation.

Authors:  Anna Villa; Luigi D Notarangelo
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

5.  Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model.

Authors:  Khie Khiong; Masaaki Murakami; Chika Kitabayashi; Naoko Ueda; Shin-ichiro Sawa; Akemi Sakamoto; Brian L Kotzin; Stephen J Rozzo; Katsuhiko Ishihara; Marileila Verella-Garcia; John Kappler; Philippa Marrack; Toshio Hirano
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 6.  Murine models of Omenn syndrome.

Authors:  Serre-Yu Wong; David B Roth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

7.  Igf-I stimulates in vivo thymopoiesis after stem cell transplantation in a child with Omenn syndrome.

Authors:  Nina S Ma; Ami J Shah; Mitchell E Geffner; Neena Kapoor
Journal:  J Clin Immunol       Date:  2009-09-24       Impact factor: 8.317

8.  Genetic Counseling in Primary Immunodeficiency Disorders: An Emerging Experience in Egypt.

Authors:  Rabab E El Hawary; Safa S Meshaal; Dalia S Abd Elaziz; Marwa A Elsharkawy; Radwa S Alkady; Sohilla Lotfy; Ahmad El-Sheikhah; Amr Hassan; Nermeen M Galal; Jeannette A Boutros; Aisha M Elmarsafy
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

9.  A RAG1 mutation found in Omenn syndrome causes coding flank hypersensitivity: a novel mechanism for antigen receptor repertoire restriction.

Authors:  Serre-Yu Wong; Catherine P Lu; David B Roth
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

10.  Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.

Authors:  Osama Alsmadi; Abdulaziz Al-Ghonaium; Saleh Al-Muhsen; Rand Arnaout; Hasan Al-Dhekri; Bandar Al-Saud; Fadi Al-Kayal; Haya Al-Saud; Hamoud Al-Mousa
Journal:  BMC Med Genet       Date:  2009-11-13       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.